Home > Healthcare > Medical Devices > Diagnostic Devices > Cerebral Oximetry Monitoring Market

Cerebral Oximetry Monitoring Market Analysis

  • Report ID: GMI6544
  • Published Date: Aug 2023
  • Report Format: PDF

Cerebral Oximetry Monitoring Application Market Analysis

Based on application, the cerebral oximetry monitoring market is segmented as cardiac surgery, vascular surgery, and others. The cardiac surgery segment accounting over 51% revenue share in 2022. Cardiac surgeries, including cardiopulmonary bypass, can increase the risk of oxygen deprivation and ischemia in the brain due to altered blood flow. Cerebral oximetry monitoring provides real-time feedback on cerebral oxygen saturation, allowing healthcare providers to optimize perfusion and ensure adequate oxygen supply to the brain during the procedure. For instance, according to the NCBI data, in 2022, around 400,000 cardiopulmonary bypass surgeries are performed annually in North America and is estimated to increase in the near future. Cerebral oximetry monitoring helps reduce the risk of post-operative neurological complications, such as stroke or cognitive impairment.
 

Cardiovascular diseases, including heart attacks and heart failures, are among the leading causes of morbidity and mortality worldwide. As the prevalence of cardiovascular diseases increases, the number of cardiac surgeries performed also rises, leading to a higher demand for these patient monitoring devices to safeguard brain health during these interventions. Therefore, the rising incidence of cardiovascular diseases, growing awareness and recommendations advancements in technology, focus on patient safety, and favourable reimbursement policy is thereby increasing the demand for cerebral oximetry monitoring in cardiac surgery.
 

Based on age group, the cerebral oximetry monitoring market is segmented as adult and pediatric. The adult segment exceeded USD 133.4 million in 2022. As the global population ages, there is a higher prevalence of age-related medical conditions, including cardiovascular diseases, neurodegenerative disorders, and other medical conditions that may necessitate surgical interventions. Cerebral oximetry monitoring are essential devices in these cases to ensure optimal brain oxygenation during medical procedures. Neurological disorders, such as stroke, traumatic brain injury, and neurodegenerative diseases, are becoming more common among the adult population.
 

Cerebral oximetry monitoring aids in managing these conditions and guiding treatment decisions. Hospitals and healthcare institutions are placing increased emphasis on perioperative care to optimize patient outcomes specifically among adult population. Cerebral oximetry monitoring plays a vital role in perioperative care for adults by helping healthcare providers identify and address potential cerebral oxygenation issues during and after surgeries.
 

 Cerebral Oximetry Monitoring Market Share, By End-use,

Based on end-use, the cerebral oximetry monitoring market is segmented as hospitals, ambulatory surgical centers and others. The hospitals segment held a dominant business share and accounted for around USD 99 million in 2022. Hospitals offer cerebral oximetry monitoring for a variety of neurological ailments that demonstrate a commitment to patient safety and quality of care. Patients prefer hospitals that utilize advanced monitoring technologies to ensure optimal outcomes, especially for high-risk procedures or surgeries. Hospitals equipped with cerebral oximetry monitoring devices are likely to attract patients that require specialized medical interventions, such as complex surgeries or critical care.
 

Patients seeking advanced treatments are more likely to choose hospitals with the latest monitoring capabilities. Patients with chronic conditions that require continuous monitoring of brain oxygenation prefer hospitals that offer cerebral oximetry monitoring as part of their long-term health management. The ability to provide integrated care within a hospital setting enhances patient outcomes and drives the demand for hospital-based services. Thus, availability and accessibility to advanced diagnosis and treatment incorporating cerebral oximetry monitoring devices coupled with the rising prevalence of chronic ailments will surge patient visits to hospitals.
 

North America Cerebral Oximetry Monitoring Market

North America cerebral oximetry monitoring market was valued at USD 85.6 million in 2022. This high market share is ascribed to a variety of factors, including the presence of significant industry players, an increase in the number of patients suffering from neurological disorders, an expanding elderly population, among others. The increasing prevalence of neurological disorders, such as stroke, traumatic brain injury, and epilepsy, emphasizes the need for precise and continuous monitoring of brain oxygenation.
 

Cerebral oximetry devices provide critical data that aids in diagnosis, treatment planning, and ongoing patient management. Healthcare facilities in North America are continuously integrating advance, accurate and user-friendly cerebral oximetry monitoring devices making it easier for healthcare professionals to adopt and utilize the technology.
 

Favorable reimbursement policies in the region for procedures involving cerebral oximetry monitoring, incentivize healthcare facilities to invest in the technology. Various government and non-government organizations are emphasizing on awareness regarding the benefits of cerebral oximetry monitoring through educational programs, medical conferences, and peer-reviewed publications.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Cerebral oximetry monitoring industry value was around USD 205.6 million in 2022 and will reach over USD 410.7 million by 2032.

The cardiac surgery dominated the cerebral oximetry monitoring industry with over 51% share in 2022 as these surgeries, including cardiopulmonary bypass, can increase the risk of oxygen deprivation and ischemia in the brain due to altered blood flow.

North America cerebral oximetry monitoring market size was USD 85.6 million in 2022 and will grow significantly through 2032 owing to the presence of significant industry players, an increase in the number of patients suffering from neurological disorders, an expanding elderly population.

Edwards Lifesciences Corporation, GE Healthcare, Hamamatsu Photonics K.K., ISS, Inc., Masimo Corporation, Medtronic plc, Mespere LifeSciences, Mindray Medical International Ltd., Nihon Kohden Corporation, Nonin Medical, Inc., Sentec AG, Terumo Cardiovascular Systems Corporation among others.

Cerebral Oximetry Monitoring Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 209
  • Countries covered: 18
  • Pages: 145
 Download Free Sample